av-gbm-1
Vaccineexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Jun 20, 2018 (NCT03400917)
Timeline
Indications
Studied for
Mechanism of action
- Tumor antigensImmunity, active
Tumor antigens immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05100641 | Phase 3 | Mar 31, 2022 | AiVita Biomedical, Inc. |
| NCT03400917 | Phase 2 | Jun 20, 2018 | AiVita Biomedical, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| AiVita Biomedical, Inc. | For profit | 2 | 2 | 2 | 2018 |
1 organizations
Page 1 / 1